Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones11-15 06:24

DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slid 4.87% to $21.69 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.64% to 19,107.65 and Dow Jones Industrial Average falling 0.47% to 43,750.86.

This was the stock's fourth consecutive day of losses.

Catalyst Pharmaceuticals Inc. closed $2.58 below its 52-week high ($24.27), which the company reached on November 8th.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.89% to $151.87, Pfizer Inc. $(PFE)$ fell 2.62% to $26.02, and Abbott Laboratories $(ABT)$ fell 0.61% to $115.03.

Trading volume (1.2 M) eclipsed its 50-day average volume of 952,094.

Data source: Dow Jones Market Data, FactSet. Data compiled November 14, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

November 14, 2024 17:24 ET (22:24 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483356272?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-15 06:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483356272","market":"fut","top_or_hot":-1,"title":"Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Catalyst Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/CPRX\">$(CPRX)$</a> slid 4.87% to $21.69 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.64% to 19,107.65 and Dow Jones Industrial Average  falling 0.47% to 43,750.86. \n</p>\n<p>\n     This was the stock's fourth consecutive day of losses. \n</p>\n<p>\n     Catalyst Pharmaceuticals Inc. closed $2.58 below its 52-week high ($24.27), which the company reached on November 8th. \n</p>\n<p>\n     The stock underperformed when compared to some of its competitors Thursday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 0.89% to $151.87, Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 2.62% to $26.02, and Abbott Laboratories <a href=\"https://laohu8.com/S/ABT\">$(ABT)$</a> fell 0.61% to $115.03. \n</p>\n<p>\n     Trading volume (1.2 M) eclipsed its 50-day average volume of 952,094. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled November 14, 2024. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2024 17:24 ET (22:24 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCatalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-15 06:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n    ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CPRX","symbol_name":"Catalyst Pharmaceutical Partners","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2483356272","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483356272","pubTimestamp":1731623040,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Catalyst Pharmaceuticals Inc.  slid 4.87% to $21.69 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.64% to 19,107.65 and Dow Jones Industrial Average  falling 0.47% to 43,750.86.This was the stock's fourth consecutive day of losses.Catalyst Pharmaceuticals Inc. closed $2.58 below its 52-week high , which the company reached on November 8th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 0.89% to $151.87, Pfizer Inc.  fell 2.62% to $26.02, and Abbott Laboratories  fell 0.61% to $115.03.Trading volume  eclipsed its 50-day average volume of 952,094.Data source: Dow Jones Market Data, FactSet. Data compiled November 14, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"CPRX":"Catalyst Pharmaceutical Partners"},"translate_title":"与竞争对手相比，Catalyst Pharmaceuticals Inc.股票周四表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CPRX":1},"content_text":"DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slid 4.87% to $21.69 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.64% to 19,107.65 and Dow Jones Industrial Average  falling 0.47% to 43,750.86. \n\n\n     This was the stock's fourth consecutive day of losses. \n\n\n     Catalyst Pharmaceuticals Inc. closed $2.58 below its 52-week high ($24.27), which the company reached on November 8th. \n\n\n     The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.89% to $151.87, Pfizer Inc. $(PFE)$ fell 2.62% to $26.02, and Abbott Laboratories $(ABT)$ fell 0.61% to $115.03. \n\n\n     Trading volume (1.2 M) eclipsed its 50-day average volume of 952,094. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled November 14, 2024. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2024 17:24 ET (22:24 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483356272"}